APP and early-onset autosomal dominant Alzheimer disease: This possibility is supported by studies indicating that MLT protects neurons from the toxicity of beta-amyloid peptide (the main neurotoxin involved in Alzheimer’s disease) by activating GABAergic receptors (Louzada et al., 2004).